Abstract

PurposePrevious studies have demonstrated that total cervical disc replacement (cTDR) represents a viable treatment alternative to the ‘gold standard’ anterior cervical discectomy and fusion for the treatment of well-defined cervical pathologies at short- and mid-term follow-up (FU). However, the implementation and acceptance of a non-fusion philosophy is closely associated with its avoidance of adjacent segment degeneration. Proof of the functional sustainability and clinical improvement of symptoms at long-term FU is still pending. The aim of this ongoing prospective study was to investigate the clinical and radiological results of cTDR at long-term FU.Methods50 patients were treated surgically within a non-randomised prospective study framework with cTDR (ProDisc C™, Synthes, Paoli, PA, USA). Patients were examined preoperatively followed by routine clinical and radiological examinations at 1, 5 and 10 years after surgery, respectively. In addition to the clinical scores, conventional X-ray images of the cervical spine were taken in anteroposterior and lateral view as well as flexion/extension images. Clinical outcome scores included parameters such as the Neck Disability Index (NDI), Visual Analogue Scale (VAS), arm and neck pain self-assessment questionnaires as well as subjective patient satisfaction rates. The radiological outcome variables included the range of motion (ROM) of the implanted prosthesis between maximum flexion and extension images, the occurrence of heterotopic ossifications and radiographic signs of adjacent segment degenerative changes. The reoperation rate following cTDR was recorded as a secondary outcome variable.ResultsA significant and maintained clinical improvement of all clinical outcome scores was observed after a mean FU of 10.2 years (VASarm 6.3–2.1; VASneck 6.4–1.9; NDI 21–6; p < 0.05). An increase in the incidence and the extent of heterotopic ossifications was noted during the post-operative course with a significant influence on the function of the prosthesis, which, however, did not reveal any detrimental effect on the patients’ clinical symptomatology. Prosthesis mobility declined from 9.0° preoperatively and 9.1° at 1 year FU to 7.7° and 7.6° at the five- and ten-year FU examinations, respectively. Radiological signs of adjacent segment degeneration were detected in 13/38 (35.7%), however, in only 3/38 (7.9%) patients this radiological changes were associated with clinical symptoms requiring conservative treatment. Intraoperative technical failure in two cases required interbody fusion with a cage (2/50). One patient (1/48, 2.1%) treated this motion device had revision surgery at the index level.ConclusionCervical total disc replacement with ProDisc C demonstrated a significant and maintained improvement of all clinical outcome parameters at a follow-up of ≥10 years. The present long-term data reveal that with an exceptionally low implant-related reoperation rate and low symptomatic adjacent segment degeneration rate, cTDR may be regarded as a safe and viable treatment option.

Highlights

  • Over the past decade, total cervical disc replacement has been established as a viable treatment option for a variety of pathologies at a short- and mid-term followup (FU)

  • Purpose Previous studies have demonstrated that total cervical disc replacement represents a viable treatment alternative to the ‘gold standard’ anterior cervical discectomy and fusion for the treatment of well-defined cervical pathologies at short- and mid-term follow-up (FU)

  • The implementation and acceptance of a nonfusion philosophy is closely associated with its avoidance of adjacent segment degeneration

Read more

Summary

Introduction

Total cervical disc replacement (cTDR) has been established as a viable treatment option for a variety of pathologies at a short- and mid-term followup (FU). Clinical studies have demonstrated this procedure to be a viable treatment alternative to the gold standard anterior cervical discectomy and fusion (ACDF) [1,2,3,4,5,6,7,8,9]. As a benchmark reference study, Hilibrand et al [10] revealed an incidence of 2.9% ASD annually over a ten-year period following ACDF. In their cohort, more than 25% of patients developed adjacent segment degenerative changes within ten years postoperatively, and more than 2/3 of these patients required further surgical intervention due to failed conservative therapy.

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.